Zydus Cadila Covid vaccine to be part of national vaccination programme soon: Health Ministry
3 years, 2 months ago

Zydus Cadila Covid vaccine to be part of national vaccination programme soon: Health Ministry

India Today  

The health ministry has said that Zydus Cadila's Covid-19 vaccine would be introduced in the national vaccination programme very shortly. Union health secretary Rajesh Bhushan said, “Zydus Cadila vaccine has been given approval. We are in conversation with the manufacturers about the pricing of the vaccine.” “Since it is a 3-dose vaccine, it would have differential pricing than the currently used vaccines,” added Rajesh Bhushan. Also watch: India approves Zydus Cadila's DNA based Covid vaccine for emergency use

India Covid Vaccine Icmr Dr Balram Bhargava Zydus Cadila  national  trials  pricing  soon  programme  ministry  cadilas  health  covid  india  zydus  balram  icmr  cadila  rajesh  vaccination  vaccine

History of this topic

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
1 year, 11 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs
2 years, 7 months ago

India’s ‘other’ COVID vaccines: Status of under-trial & approved but unused jabs

The Hindu  

As India nears the 200-crore COVID-19 vaccination mark, Serum Institute of India’s Covishield accounts for 80 per cent of the jabs, while Bharat Biotech’s Covaxin accounts for 16.75 per cent jabs. As of date, India has granted emergency usage authorisation to nine COVID-19 vaccine candidates in total – Covishield, Covaxin, Covovax, Corbevax, Zydus Cadila’s ZyCoV-D, Moderna’s Spikevax, Sputnik-V, Sputnik Light, …

India clears 2 vaccines for kids under 12 years
2 years, 7 months ago

India clears 2 vaccines for kids under 12 years

Hindustan Times  

India’s drug regulator on Tuesday approved the emergency use of two Covid-19 vaccines, Biological E’s Corbevax and Bharat Biotech’s Covaxin, for children under the age of 12 years – a milestone move that paves the way for that cohort in the country to receive a vaccine shot against the disease for the first time. Currently, Bharat Biotech’s Covaxin, an inactivated …

Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids
2 years, 7 months ago

Covaxin, Corbevax, ZyCoV-D Get DCGI Green Signal for Kids

News 18  

In the wake of schools reporting a spike in coronavirus cases among children, the Drugs Controller General of India has approved the restricted emergency use of three vaccines for different age groups of children — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D. Covaxin has received the emergency use authorisation for the age group of 6 to 12 …

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab
2 years, 7 months ago

Covaxin Gets DCGI Nod for Kids Aged 6-12 Yrs; Corbevax Cleared for 5-12 Yr Olds; 12+ to Get Zydus Jab

News 18  

In a move that could mitigate the vulnerability of children to the SAR-COV-2 virus, the Drug Controller General of India gave a restricted emergency use authorisation to three vaccines — Bharat Biotech’s Covaxin, Biological E’s Corbevax and Zydus Cadila’s ZyCov-D — for various age groups of children. Last week, the expert panel of India’s apex drug regulator recommended grant of …

Govt panel approves use of Corbevax for 5-12 year age group
2 years, 8 months ago

Govt panel approves use of Corbevax for 5-12 year age group

India Today  

Expert panel of Drug Controller General of India -- India’s drug regulator-- has recommended granting emergency use authorisation for Biological E's Covid-19 vaccine Corbevax for children in 5 to 12 years age group. "The Subject Expert Committee on COVID-19 of the CDSCO which deliberated on Biological E's EUA application has recommended granting emergency use authorisation for use of Corbevax in …

DCGI grants restricted EUA to COVID jab Corbevax for 12-18 age group
2 years, 10 months ago

DCGI grants restricted EUA to COVID jab Corbevax for 12-18 age group

Deccan Chronicle  

New Delhi/Hyderabad: The Drugs Controller General of India has granted restricted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for the 12 to 18 years age group, subject to certain conditions, official sources said on Monday. The DCGI's approval comes after the Subject Expert Committee on COVID-19 of the CDSCO on February 14 recommended granting restricted EUA to Corbevax …

Biological E\'s Corbevax vaccine granted approval for use in children aged 12-18
2 years, 10 months ago

Biological E\'s Corbevax vaccine granted approval for use in children aged 12-18

Deccan Chronicle  

Hyderabad: The Drugs Controller General of India on Monday approved Hyderabad-based Pharmaceutical company Biological E's Covid vaccine, Corbevax, for use among children in 12-18 years age group. Corbevax is India's first indigenously developed Receptor Binding Domain Protein sub-unit vaccine against the coronavirus infection. Meanwhile, the vaccine is safe and offers good immunogenicity and higher antibody levels than some other vector …

Biological E's Covid Vaccine Corbevax Gets Emergency Nod For Children Aged 12-18 Years
2 years, 10 months ago

Biological E's Covid Vaccine Corbevax Gets Emergency Nod For Children Aged 12-18 Years

ABP News  

New Delhi: The Drugs Controller General of India on Monday gave emergency use approval to Biological E's Covid-19 vaccine 'Corbevax' for inoculating children aged 12-18 years. Biological E Limited's Corbevax vaccine, India's first indigenously developed Receptor Binding Domain Protein sub-unit vaccine against #COVID-19, has received emergency use authorisation from India's drug regulator for the 12 to 18-year age group: Biological …

Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts
2 years, 10 months ago

Covovax, Corbevax, ZyCov-D Not Rolled Out Months After DCGI Nod; Now is Right Time, Say Experts

News 18  

Three vaccines – Covovax, Biological E’s jab Corbevax, and Zydus Cadila’s ZyCoV-D vaccine – approved last year by the Drug Controller General of India for emergency use are yet to be rolled out in the vaccination drive. Experts opine that now is the right time to roll out the vaccines as India has started immunizing adolescents and giving precautionary dose …

Narendra Modi's Address Updates: Vaccine for 15-18 Age Group from Jan, 3rd 'Precaution' Dose for Healthcare Workers, 60+
2 years, 11 months ago

Narendra Modi's Address Updates: Vaccine for 15-18 Age Group from Jan, 3rd 'Precaution' Dose for Healthcare Workers, 60+

News 18  

India will start vaccinating children between the ages of 15 and 18 from January 3 next year, Prime Minister Narendra Modi announced in a sudden address to the nation amid the rising cases of Omicron in the country. The news also comes as the Drug Controller General of India on Saturday gave Bharat Biotech approval for emergency use authorisation of …

Bharat Biotech's Covaxin gets DCGI nod for emergency use for children aged 12-18
2 years, 11 months ago

Bharat Biotech's Covaxin gets DCGI nod for emergency use for children aged 12-18

Firstpost  

With this, Covaxin becomes the second COVID-19 vaccine cleared for use for children in India. In August, Zydus Cadila’s three-dose DNA jab was allowed to be used on all over the age of 12 Bharat Biotech’s Covaxin, India’s indigenous COVID-19 vaccine, received approval from drug regulator DCGI for emergency use for children aged between 12-18 years on Saturday. Bharat Biotech …

Securing the young: The Hindu Editorial on COVID-19 vaccines for children and booster shots
3 years ago

Securing the young: The Hindu Editorial on COVID-19 vaccines for children and booster shots

The Hindu  

The Pune-based Serum Institute of India has said that it will be ready with vaccines for children in the next six months. Covovax is SII’s brand name for Novavax, the recombinant nanoparticle protein-based vaccine developed by the U.S.-based Novavax Inc., and this will be an important vaccine to watch out for because it will roll out from the SII stable, …

Increased severity in kids, more hospitalisations: Preliminary report on Omicron from South Africa
3 years ago

Increased severity in kids, more hospitalisations: Preliminary report on Omicron from South Africa

India Today  

A clinical summary presented by a group of physicians and public health experts to the World Health Organization has pointed to a sharp rise in hospital admissions in Covid-positive kids above the age of two in South Africa. ‘PROTECT CHILDREN’ Meanwhile, the WHO office for Europe said Tuesday that children in the 5 to 14 age group now account for …

India's First Needle-free Covid Vaccine to Hit Market: Here's All About the 3-dose ZyCov-D Jab
3 years ago

India's First Needle-free Covid Vaccine to Hit Market: Here's All About the 3-dose ZyCov-D Jab

News 18  

After the first indigenous Covid-19 vaccine, Covaxin, India is all set to roll out its second made-in-India vaccine. It is a needle-free vaccine administered in three doses, tested at Central Drug Laboratory at Kasauli in Himachal Pradesh and manufactured by Cadila Healthcare. The official further said the company’s vaccine is based on “plug and play technology” as it can be …

ZyCoV-D, India’s First Covid Vaccine for Children Aged 12+, to be Administered Among Adults in 7 States First
3 years ago

ZyCoV-D, India’s First Covid Vaccine for Children Aged 12+, to be Administered Among Adults in 7 States First

News 18  

ZyCoV-D, the first Covid-19 vaccine to be cleared by India’s drug regulator for those aged 12 and above, will be administered to adults first, News18 has learnt. The Zydus Cadila shot will not be part of the national vaccination drive initially but will be introduced in seven states first, a top government official privy to the developments said. The ZyCoV-D …

2,37,530 Doses of Needle-free Covid Vaccine ZyCoV-D Released for Use from CDL after Testing
3 years ago

2,37,530 Doses of Needle-free Covid Vaccine ZyCoV-D Released for Use from CDL after Testing

News 18  

Seven batches comprising 2,37,530 doses of India’s first DNA vaccine ZyCoV-D to fight Covid, manufactured by Cadila Healthcare, have been released after being tested by the Central Drug Laboratory in Kasauli. In addition to that, 466 batches of Covaxin, 549 of Covishield, seven of Janssen and 24 batches of Sputnik V have also been released, Dr Arun Bhardwaj, director, CDL, …

Centre Orders 1 Crore Shots of Zydus Cadila's Covid-19 Vaccine at Rs 265 Per Dose
3 years, 1 month ago

Centre Orders 1 Crore Shots of Zydus Cadila's Covid-19 Vaccine at Rs 265 Per Dose

News 18  

The central government has placed an order of one crore doses of Zydus Cadila’s ZyCoV-D, the world’s first plasmid DNA vaccine, at Rs 265 per dose, the company said in a statement on Monday. The needle-free applicator will cost Rs 93 per dose, excluding GST, the company said, adding that the pricing has been decided in consultation with the Centre. …

Centre places purchase order for one crore doses of Zydus Cadila’s Covid vaccine
3 years, 1 month ago

Centre places purchase order for one crore doses of Zydus Cadila’s Covid vaccine

Live Mint  

Zydus Cadila's three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation programme this month with the Centre placing a purchase order with the Ahmedabad-based firm for one crore doses, official sources said on Sunday. "The Centre has already placed a purchase order with Zydus Cadila for supply of one crore doses of ZyCoV-D, each costing …

Zydus Cadila Agrees to Reduce Covid Vaccine Price to Rs 265 a Dose, Final Decision Soon: Sources
3 years, 1 month ago

Zydus Cadila Agrees to Reduce Covid Vaccine Price to Rs 265 a Dose, Final Decision Soon: Sources

News 18  

Zydus Cadila has agreed to bring down the price of its Covid-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday. To administer the needle-free ZyCov-D vaccine, a disposable painless jet applicator costing Rs 93 is required for each dose, which would take the …

Zydus Cadila agrees to reduce its Covid vaccine price to ₹265 a dose, final decision soon: Report
3 years, 1 month ago

Zydus Cadila agrees to reduce its Covid vaccine price to ₹265 a dose, final decision soon: Report

Live Mint  

Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to ₹265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday. To administer the needle-free ZyCov-D vaccine, a disposable painless jet applicator costing ₹93 is required for each dose, which would take the price to …

Covaxin added to approved list of Covid vaccines for travel to Oman without quarantine
3 years, 1 month ago

Covaxin added to approved list of Covid vaccines for travel to Oman without quarantine

India TV News  

Covaxin -- India's indigenously developed vaccine by Bharat Biotech -- has now been added to the approved list of Covid-19 vaccines for travel to Oman without quarantine, Indian Embassy in Oman informed on Wednesday. Though Covaxin has been added to the Oman approval list, however, Bharat Biotech is still awaiting its vaccine's approval from the World Health Organization, which on …

Explained | Will the 2-18 age group in India get COVID-19 vaccines soon?
3 years, 2 months ago

Explained | Will the 2-18 age group in India get COVID-19 vaccines soon?

The Hindu  

The story so far: The Subject Expert Committee, which is advising the Drugs Controller-General of India, has recommended that it grant emergency use authorisation for Covaxin among children aged 2-18. Gavi, the Vaccine Alliance, commenting on the value of COVID-19 vaccines for children, says that considering that children under the age of 18 form a large proportion of the population, …

Covid-19 Vaccination Drive Will Get Tougher From This Point On, Says Scientist Gagandeep Kang
3 years, 2 months ago

Covid-19 Vaccination Drive Will Get Tougher From This Point On, Says Scientist Gagandeep Kang

News 18  

While India has performed exceptionally well in administering over 100 crore doses of Covid-19 vaccines, it’s going to get tougher from here on, vaccine expert Dr Gagandeep Kang told News18.com in an exclusive interview. “When compared to the rest of the world, India is in a very good position,” said Dr Kang, professor with The Wellcome Trust Research Laboratory, Christian …

100 Crore Covid Vaccine Doses: India's Journey to Achieving Feat and the Many Milestones along the Way
3 years, 2 months ago

100 Crore Covid Vaccine Doses: India's Journey to Achieving Feat and the Many Milestones along the Way

News 18  

India has crossed the landmark of vaccinating 100 crore individuals, becoming the second country after China to reach the milestone. On August 26, the country reached the mark of giving at least one jab to half of its 94-crore adult population and, on the very next day, it crossed the ‘1 crore doses a day vaccination’ mark for the first …

COVID-19 vaccine for children still away: Government
3 years, 2 months ago

COVID-19 vaccine for children still away: Government

The Hindu  

The government will take a final decision on vaccinating children and adolescents against coronavirus on the basis of overall scientific rationale as well as the supply situation of vaccines available for those below 18 years old, COVID Task Force chief V K Paul said on Sunday. We will take a final decision based on the overall scientific rationale and the …

When is the ideal time for children to get the COVID-19 vaccine? Experts give their opinion
3 years, 2 months ago

When is the ideal time for children to get the COVID-19 vaccine? Experts give their opinion

Firstpost  

Arora said, “Very soon, mRNA vaccine is also coming. Based on international data, it is very encouraging that we can use that for children.” A Subject Expert Committee has ruled that Bharat Biotech’s Covaxin is safe for children between 2-18 years of age. In May, during a virtual conference, Dr Tedros Adhanom Ghebreyesus, World Health Organisation’s Director-General said that while …

60 lakh ZyCoV-D's Needle-free Vaccine Doses Ready: Report
3 years, 2 months ago

60 lakh ZyCoV-D's Needle-free Vaccine Doses Ready: Report

News 18  

A day after Bharat Biotech’s Covaxin was approved for emergency use for children in the 2 to 18 age group, there’s more good news. A total of 60 lakh doses of Zydus Cadila’s ZyCoV-D vaccine are ready after production, according to top government sources quoted in a report by news agency Asian News International. According to the ANI report, in …

Covid-19 Vaccine for Kids Soon: A Look at All the Options Besides Covaxin, ZyCov-D
3 years, 2 months ago

Covid-19 Vaccine for Kids Soon: A Look at All the Options Besides Covaxin, ZyCov-D

News 18  

After the subject expert committee approved Covaxin for emergency use on children aged 2 to 18, worried parents can now heave a sigh of relief. This is an encouraging news that the central drug authority has recommended granting emergency use authorisation to Covaxin for children in the 2 to 18 years age group with certain conditions. Even as Bharat Biotech …

Abiding By Centre's Supply Principle, Kids’ Vaccine ZyCoV-D To Be Supplied To Private Hospitals
3 years, 2 months ago

Abiding By Centre's Supply Principle, Kids’ Vaccine ZyCoV-D To Be Supplied To Private Hospitals

News 18  

The first vaccine approved for use among children in the age group of 12-17 in India namely ZyCoV-D, will also be made available to private sector hospitals across the country as per reports. “If there are buyers, up to 25 lakh doses of the ZyCoV-D would be made available to private sector hospitals every month as the initial monthly vaccine …

Covid vaccine for children by December: Karnataka Health Minister
3 years, 2 months ago

Covid vaccine for children by December: Karnataka Health Minister

India TV News  

Karnataka's Minister for Health K. Sudhakar has announced that Covid-19 vaccines in the form of nasal drops for children would mostly be available by the month of November or December. Speaking to reporters in New Delhi after his meeting with Union Minister for Health Mansukh Mandaviya on Sunday, Sudhakar said that the Central government is negotiating the price of Covid-19 …

National Rollout of Zydus Cadila’s Vaccine As Early as Oct 15, Says NTAGI Chief, Final Checks On
3 years, 2 months ago

National Rollout of Zydus Cadila’s Vaccine As Early as Oct 15, Says NTAGI Chief, Final Checks On

News 18  

With the national rollout of Zydus Cadila’s Covid vaccine, ZyCoV-D just 2 weeks away, different batches of ZyCoV-D are undergoing a final round of quality checks at the vaccine testing laboratory in Himachal Pradesh. Talking to TOI, NK Arora, chairman of the Centre’s Covid working group of the National Technical Advisory Group on Immunisation expressed that if everything works out …

Zydus Cadila Quotes Rs 1,900 for Its Covid Vaccine Shot; Govt in Talks to Curtail Price
3 years, 2 months ago

Zydus Cadila Quotes Rs 1,900 for Its Covid Vaccine Shot; Govt in Talks to Curtail Price

News 18  

Around 1.5 lakh doses of Zydus Cadila’s ZyCoV-D vaccine have cleared the quality test at Central Drugs Laboratory, in Kasauli, Himachal Pradesh, sources told CNN-News18, adding that the government is currently in negotiation with the manufacturers to bring down the commercial price of the jab. It has taken longer for the government and manufacturers to negotiate the price of the …

Centre Hopeful of Positive Outcome from Talks with Zydus Cadila for Covid Vaccine for Kids: K'taka Min
3 years, 2 months ago

Centre Hopeful of Positive Outcome from Talks with Zydus Cadila for Covid Vaccine for Kids: K'taka Min

News 18  

The Centre is hopeful of a positive outcome from the final round of discussions currently underway with Zydus Cadila for its COVID-19 vaccine for children, Karnataka Health Minister K Sudhakar said on Sunday after a meeting with Union Health Minister Mansukh Mandaviya here in the national capital. Sudhakar, who discussed children’s vaccination and other state initiatives over a breakfast meeting …

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid
3 years, 2 months ago

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid

News 18  

Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat Covid-19. “As the world needs Covid-19 vaccines, the world also needs proven and effective Covid-19 therapies,” Lahariya said. List of Drugs in the Pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral …

Covid-19 Booster Shots Not Imp, Govt Focusing on Vaccinating Adult Population: ICMR DG
3 years, 2 months ago

Covid-19 Booster Shots Not Imp, Govt Focusing on Vaccinating Adult Population: ICMR DG

News 18  

Union Health Ministry on Thursday said the rollout of the third dose of the Covid-19 vaccine or booster shots was not important and the government is focusing on providing complete vaccine cover to the entire adult population in the national inoculation drive. Announcing the decision, top Israeli health officials said the effectiveness of the second dose of the Pfizer-BioNTech vaccine …

Covid Vaccine For Kids Soon? Govt to Make Zydus Cadila's 3-dose Jab Part of National Drive
3 years, 2 months ago

Covid Vaccine For Kids Soon? Govt to Make Zydus Cadila's 3-dose Jab Part of National Drive

News 18  

Zydus Cadila?s Covid-19 DNA vaccine will be?introduced? On August 20, DCGI approved Zydus Cadila vaccine for emergency use in adults and children aged 12 years and above. LIVE Updates At the weekly health ministry briefing, Health Secretary Rajesh Bhushan said:?Zydus vaccine will be introduced very soon. Last week, responding to a question at a press conference, NITI Aayog Member Dr …

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October
3 years, 2 months ago

Centre working with Zydus Cadila on pricing of ZyCoV-D vaccine; likely to launch on 2 October

Firstpost  

The government is aiming to roll out India’s first approved vaccine for kids aged 12 years and above on 2 October, the birthday of Mahatma Gandhi The Central government, along with pharmaceutical company Zydus Cadila is likely to take a call on the pricing of ZyCov-D, the world’s first DNA vaccine to fight COVID-19, with the launch likely on 2 …

India Allows Serum Institute to Enrol 7-11-year-olds in Novavax Covid-19 Vaccine Trial
3 years, 2 months ago

India Allows Serum Institute to Enrol 7-11-year-olds in Novavax Covid-19 Vaccine Trial

News 18  

India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's Covid-19 vaccine, as the country prepares to protect children from the novel coronavirus. "After detailed deliberation, the committee recommended for allowing enrolment of subjects of 7 to 11 years of age group as per the protocol," a …

Indian scientists working on 1st ever dengue DNA vaccine
3 years, 2 months ago

Indian scientists working on 1st ever dengue DNA vaccine

Hindustan Times  

The world’s first DNA vaccine was approved for use in India recently. Now, some researchers believe the technology -- considered superior because DNA vaccines are easier to make and store, and, most importantly store an enormous amount of information -- can be used to develop a vaccine for another tropical disease, dengue, a viral infection transmitted by mosquitoes. With the …

PM Modi’s Pitch for Home-Grown Covid Vaccines at UNGA, Invites Jab Manufacturers to India
3 years, 2 months ago

PM Modi’s Pitch for Home-Grown Covid Vaccines at UNGA, Invites Jab Manufacturers to India

News 18  

Prime Minister Narendra Modi on Saturday made a strong pitch for the home-grown coronavirus vaccines, including the world’s first plasmid DNA and nasal vaccines. Addressing the UNGA in New York, PM Modi said, “India has already developed a DNA vaccine that can be administered to people aged 12 year and above. The prime minister also asked vaccine manufacturers to come …

Modi Govt's Oct Bonanza: 1 Crore Doses of Zydus Cadila’s Covid Vaccine to Hit Markets Next Month
3 years, 3 months ago

Modi Govt's Oct Bonanza: 1 Crore Doses of Zydus Cadila’s Covid Vaccine to Hit Markets Next Month

News 18  

New Delhi: The Narendra Modi government at the Centre is planning to roll out Zydus Cadila’s Covid-19 vaccine, ZyCoVD, by the end of October, News18 has learnt. The government is expecting the delivery of one crore doses of DNA vaccine which can also be administered to adolescents aged between 12 and 17. In the coming months, India may also add …

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources
3 years, 3 months ago

Zydus Cadila's Covid vaccine ZyCoV-D launch likely in October: Sources

India TV News  

Zydus Cadila's needle-free coronavirus vaccine ZyCoV-D is likely to be launched in early October, according to sources. Indigenously developed Zydus Cadila's ZyCoV-D had received approval for Emergency Use Authorisation from the drug regulator two weeks ago, making it the first vaccine in the country which would be administered in the age group of 12-18 years. On the kind of negotiations …

Biological E.’s COVID-19 vaccine approved for advanced trials on children
3 years, 3 months ago

Biological E.’s COVID-19 vaccine approved for advanced trials on children

The Hindu  

Hyderabad-based pharmaceutical company Biological E. Limited has been approved by the Drugs Controller General of India to conduct further trials of its vaccine Corbevax on children and adolescents. Health Ministry officials said in June that the Centre had reserved 30 crore doses of the vaccine for inclusion into India’s vaccination drive. These approvals encourage our organisation to move forward and …

'ZyCoV-D Will be as Affordable as Our Other Products, Market Launch Likely by Sept-end': Zydus Group MD
3 years, 3 months ago

'ZyCoV-D Will be as Affordable as Our Other Products, Market Launch Likely by Sept-end': Zydus Group MD

News 18  

Price of India’s second home-grown Covid-19 vaccine, ZyCoV-D, will be decided basis the technology, capacity and volume, and it will be “affordable”, Dr Sharvil Patel, managing director of Zydus Group, the company manufacturing the vaccine, told News18.com. “Throughout the pandemic, Zydus has provided affordable therapeutics, diagnostics and preventives and ZyCoV-D will be no different.” ZyCoV-D — which is the world’s …

DGCI Gives Nod for Phase 2/3 Trials of Biological E's Covid Vaccine for Children
3 years, 3 months ago

DGCI Gives Nod for Phase 2/3 Trials of Biological E's Covid Vaccine for Children

News 18  

The Drugs Controller General of India on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its ‘Made in India’ COVID-19 vaccine on children aged between 5 and 18 years with certain conditions, sources said. Meanwhile, the data of phase 2/3 clinical trials of Bharat Biotech’s Covaxin in the age group 2 to 18 …

Recruitment of Volunteers for Trial of Covid Vaccine Covovax on Children Begins
3 years, 3 months ago

Recruitment of Volunteers for Trial of Covid Vaccine Covovax on Children Begins

News 18  

Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research here. Indigenously developed Zydus Cadila’s needle-free COVID-19 vaccine ZyCoV-D has received emergency use authorisation from the drug regulator, making it the first vaccine to be administered in the …

ZyCoV-D vaccine safe and effective for adolescents, says expert
3 years, 3 months ago

ZyCoV-D vaccine safe and effective for adolescents, says expert

The Hindu  

Arora, a senior member of National COVID-19 Task Force and Advisor, national AEFI committee, speaks to The Hindu about the ZyCoV-D vaccine — the world’s first plasmid DNA vaccine for human use — and how it could be the beginning of a vaccine revolution. ZyCoV-D vaccine is the world’s first plasmid DNA vaccine for human use. Any new vaccine is …

Discover Related